Influence of thyroid hormone on mouse preantral follicle development in vitro

2004 ◽  
Vol 81 ◽  
pp. 919-924 ◽  
Author(s):  
Sandra Cecconi ◽  
Gianna Rossi ◽  
Giovanni Coticchio ◽  
Guido Macchiarelli ◽  
Andrea Borini ◽  
...  
Reproduction ◽  
2007 ◽  
Vol 133 (6) ◽  
pp. 1121-1128 ◽  
Author(s):  
Fiona H Thomas ◽  
Bruce K Campbell ◽  
David G Armstrong ◽  
Evelyn E Telfer

The aim of this study was to determine the effect of regulation of IGF-I bioavailability on preantral follicle development in vitro. Bovine preantral follicles were cultured for 6 days in serum-free medium with increasing doses of Long R3 (LR3) IGF-I (an analog with low affinity for IGF-binding proteins (IGFBPs)), or human recombinant IGF-I (hrIGF-I). Follicle diameter and estradiol production were measured every second day. On day 6, ratios of oocyte/follicle diameter and oocyte morphology were assessed by histological examination, and IGFBP-2 and -3 were detected by immunocytochemistry and in situ hybridization respectively. Both types of IGF-I increased follicle diameter in a dose-dependent manner (P < 0.05) and increased estradiol production over control levels (P < 0.05). However, follicles treated with LR3 IGF-I and the highest concentration of hrIGF-I (1000 ng/ml) had smaller oocyte/follicle ratios, and increased oocyte degeneration, compared with controls or follicles treated with physiological concentrations of hrIGF-I (P < 0.05). IGFBPs were detected in cultured preantral follicles, indicating a requirement for regulation of IGF bioavailability during the early stages of follicular development. Specifically, IGFBP-3 mRNA was found to be expressed in oocytes, and IGFBP-2 immunoreactivity was detected in oocytes and granulosa cells of cultured follicles. In summary, the regulation of IGF-I bioavailability by IGFBPs is necessary for the co-ordination of oocyte and follicle development in vitro.


2015 ◽  
Vol 25 (2) ◽  
pp. 85-89 ◽  
Author(s):  
M.K.B. Serafim ◽  
A.B.G. Duarte ◽  
G.M. Silva ◽  
C.E.A. Souza ◽  
D.M. Magalhães-Padilha ◽  
...  

2018 ◽  
Vol 11 (6) ◽  
pp. 537-537
Author(s):  
Hong Zhou ◽  
Joseph T. Decker ◽  
Melissa M. Lemke ◽  
Claire E. Tomaszewski ◽  
Lonnie D. Shea ◽  
...  

Endocrinology ◽  
1995 ◽  
Vol 136 (3) ◽  
pp. 849-856 ◽  
Author(s):  
R Li ◽  
D M Phillips ◽  
J P Mather

2018 ◽  
Vol 30 (5) ◽  
pp. 779 ◽  
Author(s):  
N.-Y. Rho ◽  
F. A. Ashkar ◽  
T. Revay ◽  
P. Madan ◽  
G.-J. Rho ◽  
...  

Thyroid hormone receptor (THR) α and THRβ mediate the genomic action of thyroid hormones (THs) that affect bovine embryo development. However, little is known about THRs in the preimplantation embryo. The aim of the present study was to investigate the importance of THRs in in vitro preimplantation bovine embryos. THR transcripts and protein levels were detected in developing preimplantation embryos up to the blastocyst stage. Embryonic transcription of THRs was inhibited by α-amanitin supplementation, and both maternal and embryonic transcription were knocked down by short interference (si) RNA microinjection. In the control group, mRNA and protein levels of THRs increased after fertilisation. In contrast, in both the transcription inhibition and knockdown groups there were significant (P < 0.05) decreases in mRNA expression of THRs from the 2-cell stage onwards. However, protein levels of THRs were not altered at 2-cell stage, although they did exhibit a significant (P < 0.05) decrease from the 4-cell stage. Moreover, inhibition of de novo transcripts of THRs using siRNA led to a significant (P < 0.01) decrease in the developmental rate and cell number, as well as inducing a change in embryo morphology. In conclusion, THRs are transcribed soon after fertilisation, before major activation of the embryonic genome, and they are essential for bovine embryo development in vitro.


2001 ◽  
Vol 32 (6) ◽  
pp. 587-594 ◽  
Author(s):  
Penelope L Nayudu ◽  
Antonia Fehrenbach ◽  
Petra Kiesel ◽  
Ursula A Vitt ◽  
Katti Pancharatna ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document